Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2) (N-Term) Peptide
Quick Overview for Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2) (N-Term) Peptide (ABIN8104339)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- LZTS2 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-LZTS2 antibody ( ARP58817_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Background
-
Background Information: LZTS2 is a negative regulator of katanin-mediated microtubule severing and release from the centrosome. LZTS2 is required for central spindle formation and the completion of cytokinesis. LZTS2 may negatively regulate axonal outgrowth by preventing the for
Alternative Symbols: KIAA1813, LAPSER1, RP11-108L7.8
-
Molecular Weight
- 73kDa
-
Gene ID
- 84445
-
NCBI Accession
- NP_115805
-
UniProt
- Q9BRK4
Target
-